|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | TLC及HPLC测定红曲产品中的桔霉素显示文摘阐述了定性及定量测定红曲产品中桔霉素含量的几种方法 .采用板层析 (TLC) ,在点样量为 1mL、点样长度 5cm条件下通过目视法 ,标准桔霉素溶液的最低检测质量浓度可达 0 .2mg/L ,板层析可作为定性检验红曲产品中桔霉素的简便方法 .根据红曲样品预处理方法及HPLC检测器的不同 ,确定了两套准确可靠的定量检测方法 .高效液相色谱结合荧光检测的最低检测限为 0 .60ng .HPLC上样液最低可检测的质量浓度为 0 .1mg/L .在 0 .1~ 1 0mg/L的质量浓度范围内 ,标准桔霉素溶液的质量浓度与峰面积的线性关系良好 ,达到R2 =0 .998. | 陈蕴 许赣荣 顾玉梅 Philippe BLANC | 2001 | 无锡轻工大学学报(食品与生物技术)2001，20，2： | 38 |
| 2 | Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: A meta-analysis显示文摘AIM: To determine whether the association of β-blockers with endoscopic treatment is superior to endoscopic treatment alone for the secondary prophylaxis of oesophageal variceal bleeding. METHODS: Randomised controlled trials comparing sclerotherapy (SCL) with SCL plus β-blockers (BB) or banding ligation (BL) with BL plus BB were identif ied.Main outcomes were overall and 6, 12 and 24 mo rebleeding rates, as well as overall and 6, 12 and 24 mo mortality. Two statistical methods were used: Yusuf-Peto, and Der Simonian and Laird. Inter-trial heterogeneity was systematically taken into account. RESULTS: Seventeen randomised controlled trials were included, 14 with SCL and 3 with BL. Combination β-blocker and endoscopic treatment signif icantly reduced rebleeding rates at 6, 12 and 24 mo and overall [odds ratio (OR): 2.20, 95% conf idence interval (CI): 1.69-2.85, P<0.0001] compared to endoscopic treatment alone. Mortality at 24 mo was signif icantly lower for the combined treatment group (OR: 1.83, 95% CI:1.16-2.90, P= 0.009), as well as overall mortality (OR: 1.43, 95% CI:1.03-1.98, P= 0.03). CONCLUSION: Combination therapy should thus be recommended as the fi rst line treatment for secondary prophylaxis of oesophageal variceal bleeding. | Natalie Funakoshi Frédérique Ségalas-Largey Yohan Duny Frédéric Oberti Jean-Christophe Valats Michael Bismuth Jean-Pierre Daurès Pierre Blanc | 2010 | World Journal of Gastroenterology2010，16，47： | 24 |
| 3 | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement显示文摘 | M Dominici K Le Blanc I Mueller I Slaper-Cortenbach Fc Marini Ds Krause Rj Deans A Keating Dj Prockop Em Horwitz | 2006 | Cytotherapy2006，，4： | 11 |
| 4 | 宫颈病变与人乳头状病毒感染的相关性及干预性预防的研究显示文摘目的 :探讨HPV感染与宫颈病变的关系。方法 :分析 1996年 1月 1日~ 1998年 6月 30日在法国马塞市Conception医院妇产科进行的 2 18例宫颈锥型切除术的病理结果与HPV感染情况。结果 :HPV总阳性率为 52 75% ,CIN 3的HPV阳性率最高 ,而CIN 2的HPV阳性率比CIN 1高。结论 :宫颈癌前病变与HPV感染极相关 ,宫颈癌者HPV感染的组织病理学诊断率低 ,应积极预防宫颈癌的发生。 | 杨伶俐 侍庆 朱钟治 BLANC B | 2001 | 肿瘤防治杂志2001，8，4： | 10 |
| 5 | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement显示文摘 | M Dominici K Le Blanc I Mueller I Slaper-Cortenbach Fc Marini Ds Krause Rj Deans A Keating Dj Prockop Em Horwitz | 2006 | Cytotherapy2006，，4： | 9 |
| 6 | Genotype phenotype classification of hepatocellular adenoma显示文摘Studies that compare tumor genotype with phenotype have provided the basis of a new histological/molecular classification of hepatocellular adenomas. Based on two molecular criteria (presence of a TCF1/HNF1α or β-catenin mutation), and an additional histological criterion (presence or absence of an inflammatory infiltrate), subgroups of hepatocellular adenoma can be defined and distinguished from focal nodular hyperplasia. Analysis of 96 hepatocellular adenomas performed by a French collaborative network showed that they can be divided into four broad subgroups: the fi rst one is defi ned by the presence of mutations in TCF1 gene inactivating the hepatocyte nuclear factor 1 (HNF1α); the second by the presence of β-catenin activating mutations; the category without mutations of HNF1α or β-catenin is further divided into 2 subgroups depending on the presence or absence of in? ammation. Therefore, the approach to the diagnosis of problematic benign hepatocytic nodules may be entering a new era directed by new molecular information. It is hoped that immunohistological tools will improve significantly diagnosis of liver biopsy in our ability to distinguish hepatocellular adenoma from focal nodular hyperplasia (FNH), and to delineate clinically meaningful entities within each group to define the best clinical management. The optimal care of patients with a liver nodule will benefit from the recent knowledge coming from molecular biology and the combined expertise of hepatologists, pathologists, radiologists, and surgeons. | Paulette Bioulac-Sage Jean Frédéric Blanc Sandra Rebouissou Charles Balabaud Jessica Zucman-Rossi | 2007 | World Journal of Gastroenterology2007，13，19： | 7 |
| 7 | What lessons can be learned from y T cell-based cancer immunotherapy trials?显示文摘 | Jean-Jacques Fournie Helene Sicard Mary Poupot Christine Bezombes Amandine Blanc Franqois-Romagne Loic Ysebaert Guy Laurent | 2013 | Cellular & Molecular Immunology2013，10，1： | 7 |
| 8 | 无桔霉素红曲色素突变株FM5183对单谷氨酸钠(MSG)、组氨酸的代谢特性显示文摘经过复合诱变处理得到的产无桔霉素的红曲色素变异株 ,编号为FM51 83,在摇瓶条件下分批深层培养 ,研究了菌株在碳源为葡萄糖条件下对单谷氨酸钠 (MSG)、组氨酸的代谢特性 ,该菌株分别在含MSG和组氨酸情况下 ,对产生的中间产物苹果酸和乙醇的代谢特性进行了比较 ,结果表明 :突变菌株FM51 83产生的酒精量为 2 5~ 2 7g L ,苹果酸浓度最大值为 5 8g L ;另外 ,在含MSG和组氨酸的培养基上对产生的色素量进行测定 ,其色价分别为 2 5 5和 1 1 8,对试验所用的氮源等条件下 ,整个发酵过程未有桔霉素检出。突变菌株FM51 83是一株较理想的无桔霉素红曲色素工业化生产菌株。 | 吴祖芳 翁佩芳 张礼星 Philippe J BLANC | 2002 | 生物技术2002，12，6： | 6 |
| 9 | 混合培养微生物利用甘油补料发酵生产乙醇研究显示文摘采用浸麻芽孢杆菌和红曲菌9906利用甘油混合发酵生产乙醇.结果表明,分批发酵中高浓度的甘油对乙醇发酵有着较强的抑制作用,分批发酵最佳甘油浓度为0.217molL-1.在分批发酵的基础上补料发酵,考察了不同甘油浓度的补料液和不同补料时间对乙醇发酵的影响.最终确定乙醇补料发酵较优的工艺条件为:反应器1L,装液量700mL红曲发酵液,甘油初始浓度为0.217molL-1,以补料方式每隔60h分5次补加0.217molL-1甘油浓度的红曲发酵液,每次补加100mL,发酵培养360h.当乙醇最高浓度达0.221molL-1,乙醇总产率0.628mmolh-1,乙醇/甘油转化率达87%(molmol-1).与分批发酵相比,补料发酵很大程度解除了高浓度甘油的抑制作用,有效地利用了甘油,提高了乙醇的产量,且乙醇产率较为稳定. | 张宏武 王璐 许赣荣 BLANC Philippe J | 2008 | 应用与环境生物学报2008，14，5： | 6 |
| 10 | The Apollon 10 PW laser: experimental and theoretical investigation of the temporal characteristics显示文摘The objective of the Apollon 10 PW project is the generation of 10 PW peak power pulses of 15 fs at 1 shot min^(-1). In this paper a brief update on the current status of the Apollon project is presented, followed by a more detailed presentation of our experimental and theoretical investigations of the temporal characteristics of the laser. More specifically the design considerations as well as the technological and physical limitations to achieve the intended pulse duration and contrast are discussed. | D.N.Papadopoulos J.P.Zou C.Le Blanc G.Chriaux P.Georges F.Druon G.Mennerat P.Ramirez L.Martin A.Frneaux A.Beluze N.Lebas P.Monot F.Mathieu P.Audebert | 2016 | High Power Laser Science and Engineering2016，4，3： | 6 |
| 11 | Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications显示文摘Although it is now known that the human body is colonized by a wide variety of microbial populations in different parts(such as the mouth, pharynx and respiratory system, the skin, the gastro- and urogenital tracts), many effects of the complex interactions between the human host and microbial symbionts are still not completely understood. The dysbiosis of the gastrointestinal tract microbiota is considered to be one of the most important contributing factors in the development of many gastrointestinal diseases such as inflammatory bowel disease, irritable bowel syndrome and colorectal cancer, as well as systemic diseases like obesity, diabetes, atherosclerosis and non-alcoholic fatty liver disease. Fecal microbial transplantations appear to be promising therapies for dysbiosis-associated diseases; however, probiotic microorganisms have been growing in popularity due to increasing numbers of studies proving that certain strains present health promoting properties, among them the beneficial balance of the intestinal microbiota. Inflammatory bowel diseases andobesity are the pathologies in which there are more studies showing this beneficial association using animal models and even in human clinical trials.In this review,the association of the human gut microbiota and human health will be discussed along with the benefits that probiotics can confer on this symbiotic activity and on the prevention or treatment of associated diseases. | Alejandra de Moreno de Le Blanc Jean Guy Le Blanc | 2014 | World Journal of Gastroenterology2014，20，44： | 5 |
| 12 | Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex显示文摘 | K.Le Blanc L.Tammik B.Sundberg S. E.Haynesworth O.Ringdén | 2003 | Scandinavian Journal of Immunology2003，，1： | 3 |
| 13 | 苏云金杆菌防治储烟害虫研究进展显示文摘在所有为害贮存烟草并能造成严重损失的昆虫种类中 ,烟草甲虫Lasiodermaserricorne(F .)和烟草粉螟Ephestiaelutella(H¨ubner)是原烟及加工后烟草的 2种主要害虫。收获后烟草害虫的防治主要通过消毒、害虫监测以及磷化氢熏蒸来实现 ,而储烟害虫已对磷化氢产生抗药性 ,并已有防治失败的实例报道 ,而熏蒸也越来越受到相关法规的制约。一些生物防治剂如苏云金杆菌Bacillusthuringiensis(Bt) ,因对环境无害而有可能替代化学防治。Bt是一种细菌 ,在芽孢形成阶段能够产生杀虫晶体蛋白。Bt用作植食性害虫的生防制剂已有 4 0多年的历史。Bt产生的杀虫晶体蛋白对几个目的昆虫具有特有的生物活性 ,可对昆虫的取食产生影响。我们实验室进行了广泛的研究并在世界范围内开展了调查 ,对仓储烟草中的Bt进行评价 ,现已证实了以前的研究结果 ,即Bt是自然发生的叶面微生物群落中的一部分。已从烟草上分离出几个Bt菌株并进行了特征描述 (DNA和蛋白质图谱 )。已通过胃毒的方法对所分离的菌株以及 2个商业产品对烟草甲幼虫的杀虫活性进行了测定。在长达 30个月的贮存期内 ,对已调制烟叶上的Bt孢子及其晶体蛋白的稳定性进行了分析。Bt处理过的烟叶制成卷烟样品评吸后 ,处理与对照卷烟无显著性差异。尽管在规定的时间及剂量情? | Michel Blanc Pascale Kaelin Ferruccio Gadani 王颖 | 2003 | 烟草科技2003，36，6： | 3 |
| 14 | Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn’s Disease显示文摘 | Ingrid Ordás Jordi Rimola Sonia Rodríguez José M. Paredes María J. Martínez-Pérez Esther Blanc Juan A. Arévalo Marta Aduna Montserrat Andreu Alexander Radosevic Anna M. Ramírez-Morros Susana Pinó Marta Gallego Aranzazu Jauregui-Amezaga Elena Ricart Julián | 2013 | Gastroenterology2013，，： | 3 |
| 15 | Clinical epidemiology of chronic viral hepatitis B:A Tuscany real-world large-scale cohort study显示文摘AIM To build a regional database of chronic patients to define the clinical epidemiology of hepatitis B virus(HBV)-infected patients in the Tuscan public health care system.METHODS This study used a cross-sectional cohort design. We evaluated chronic viral hepatitis patients with HBV referred to the outpatient services of 16 hospital units. Information in the case report forms included main demographic data, blood chemistry data, viral hepatitis markers, instrumental evaluations, and eligibility for treatment or ongoing therapy and liver transplantation. RESULTS Of 4015 chronic viral hepatitis patients, 1096(27.3%) were HBV infected. The case report form was correctly completed for only 833 patients(64% males, 36% females; mean age 50.1 ± 15.4). Of these HBV-infected patients, 73% were Caucasian, 21% Asian, 4% Central African, 1% North African and 1% American. Stratifying patients by age and nationality, we found that 21.7% of HBV-infected patients were aged < 34 years(only 2.8% were Italian). The most represented routes of transmission were nosocomial/dental procedures(23%), mother-to-child(17%) and sexual transmission(12%). The most represented HBV genotypes were D(72%) and A(14%). Of the patients, 24.7% of patients were HBe Ag positive, and 75.3% were HBe Ag negative. Of the HBV patients 7% were anti-HDV positive. In the whole cohort, 26.9% were cirrhotic(35.8% aged < 45 years), and 47% were eligible for or currently undergoing treatment, of whom 41.9 % were cirrhotic. CONCLUSION Only 27.3% of chronic viral hepatitis patients were HBV infected. Our results provide evidence of HBV infection in people aged < 34 years, especially in the foreign population not protected by vaccination. In our cohort of patients, liver cirrhosis was also found in young adults. | Cristina Stasi Caterina Silvestri Roberto Berni Maurizia Rossana Brunetto Anna Linda Zignego Cristina Orsini Stefano Milani Liana Ricciardi Andrea De Luca Pierluigi Blanc Cesira Nencioni Donatella Aquilini Alessandro Bartoloni Giampaolo Bresci Santino Marchi Franco Filipponi Piero Colombatto Paolo Forte Andrea Galli Sauro Luchi Silvia Chigiotti Alessandro Nerli Giampaolo Corti Rodolfo Sacco Paola Carrai Angelo Ricchiuti Massimo Giusti Paolo Almi Andrea Cozzi Silvia Carloppi Giacomo Laffi Fabio Voller Francesco Cipriani | 2018 | World Journal of Hepatology2018，10，5： | 3 |
| 16 | A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection显示文摘 | Jean–Charles Nault Aurélien De Reyniès Augusto Villanueva Julien Calderaro Sandra Rebouissou Gabrielle Couchy Thomas Decaens Dominique Franco Sandrine Imbeaud Francis Rousseau Daniel Azoulay Jean Saric Jean–Frédéric Blanc Charles Balabaud Paulette Bioulac | 2013 | Gastroenterology2013，，1： | 3 |
| 17 | Proteomic composition of the acrostyle" Novel approaches to identify cuticular proteins involved in virus-insect interactions显示文摘 | Craig Graham Webster Maelle Thillier Elodie Pirolles Bastien Cayrol Stephane Blanc Marilyne Uzest | 2017 | Insect Science2017，24，6： | 3 |
| 18 | 国际子午圈计划的科学挑战和观测系统显示文摘随着科技发展,人类活动对地面基础设施、空间系统和太空飞行器等高科技设施的依赖性日益增强.然而,这些高科技设施却常常遭受着来自太阳活动、地震、大气和气候变化、地磁场变化,以及全球电场波动等多种危害的威胁.监测和了解这些危害,并减轻其影响,是21世纪重要的科学挑战之一.这些危害尽管形式不同,但是有一个共同之处是会在电离层和中高层大气这个地球空间环境的关键圈层留下自己的印记.国际子午圈计划是一项由中国科学院牵头的国际大科学计划,其目标是整合、部署和运行一个全球研究和监测网络,充分利用电离层和中高层大气的'显示屏'效果来追踪这些日地空间危害的踪迹.文章展示了国际子午圈计划全球观测系统所需的位置分布,即优先沿120°E~60°W大子午圈部署监测设备,实现对主要地理和地磁纬度变化的最佳覆盖,继而辅之以30°E~150°W的第二个子午圈来捕捉经度变化.而后简单地描述了中国子午工程,以及横跨中国、俄罗斯和美洲的一些国家在内的120°E~60°W大子午圈上的监测台站和设备. | 刘维宁 Michel BLANC 王赤 Eric DONAVAN John FOSTER Mark LESTER Hermann OPGENOORTH 任丽文 | 2021 | 中国科学:地球科学2021，51，12： | 3 |
| 19 | Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement显示文摘 | EM Horwitz K Le Blanc M Dominici I Mueller I Slaper-Cortenbach FC Marini RJ Deans DS Krause A Keating | 2005 | Cytotherapy2005，，5： | 2 |
| 20 | Design and current progress of the Apollon 10 PW project显示文摘The objective of the Apollon project is the generation of 10 PW peak power pulses of 15 fs at 1 shot/minute. In this paper the Apollon facility design, the technological challenges and the current progress of the project will be presented. | J.P.Zou C.Le Blanc D.N.Papadopoulos G.Chériaux P.Georges G.Mennerat F.Druon L.Lecherbourg A.Pellegrina P.Ramirez F.Giambruno A.Fréneaux F.Leconte D.Badarau J.M.Boudenne D.Fournet T.Valloton J.L.Paillard J.L.Veray M.Pina P.Monot J.P.Chambaret P.Martin F.Mathieu P.Audebert F.Amiranoff | 2015 | High Power Laser Science and Engineering2015，3，1： | 2 |
您所在的机构暂未开通此部分的功能，请联系管理员